Company Profile
Nkarta Stock Price, News & Analysis
- Ticker:
- NKTX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Nkarta is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
3.03 USD (+8.60%)
Close
Last updated: June 23, 2026 at 00:00
216.78M USD
Market cap
Why the stock is moving
NKTX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Nkarta is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Nkarta is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Nkarta follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Nkarta sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Nkarta to Participate in a September Investor Conference
Source: Nkarta
- 04
- 05
Nkarta to Participate in November Investor Conferences
Source: Nkarta
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Nkarta (NKTX)?
Nkarta (NKTX) most recently closed at 3.03 USD, a +8.60% move versus the previous session.
What is the market cap of Nkarta (NKTX)?
Nkarta currently has a market capitalization of 216.78M USD on BioPharmSignal.
What does Nkarta do?
Nkarta is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is NKTX stock listed?
Nkarta (NKTX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Nkarta is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Nkarta?
Nkarta is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Nkarta targeting with Nkarta?
Nkarta is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.